The activation of the PI3K/AKT/mTOR signaling network has been commonly observed in many human cancers, and can be triggered by a variety of mechanisms including overexpression of upstream receptors, activating PI3KCA mutations, loss of PTEN function, and overexpression or activation of AKT [5]. This evidence concerns the gene PTEN and cancer.